Microtuning a Bonafide Treatment for GAD Patients - A Randomized Controlled Trial.

NCT02039193 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
57
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Zurich

Collaborators